The characterisation of the activation domains started three decades ago with Gcn4 and Gal4 activators. The amorphous character of the activation domains strongly hindered their definition. Moreover, during the attempts to localise the Gal4 activation domain, the artificial peptides, an unintended consequence of cloning, were responsible for artificial transcriptional activity of the several Gal4 constructs. These artefacts produced enormous experimental bias and misconception. The presence of inhibitory domains in some Gal4 constructs made the misperception even worse. Previously, we reported that the nine amino acid transactivation domain, 9aaTAD, is the exclusive activation domain in the Gal4 protein. The activation domain 9aaTAD could be identified in Gal4 paralogs Oaf1, Pip2, Pdr1, Pdr3 and other activators p53, E2A and MLL. Surprisingly, the activation domain 9aaTAD was reported as misconception for Gal4 activator. Here we demonstrated that small region of 10 amino acids adjacent to the Gal4 activation domain 9aaTAD is an inhibitory domain, which the authors included in their constructs. Moreover, we identified Gal4 region, which was able to the reverse the inhibitory effect. The 9aaTAD re-activation domain was localized to the 13 amino acid long region. In this report we clarified the numerous confusions and rebutted supposed 9aaTAD misconception.
Introduction
The Nine amino acid Transactivation Domain, 9aaTAD, is universally recognized by the transcriptional machinery in eukaryotes (1) (2) (3) . Currently, the 9aaTAD family comprises of over 40 members including Gal4, Oaf1, Pip2, Pdr1, Pdr3, Leu3, Tea1, Pho4, Gln3, Gcn4, Msn2, Msn4, Rtg3, E2A, MLL, p53-TADI, p53-TADII, FOXO3, NF-kB, NFAT, CEBPA/E, ESX, ELF3, ETV1, KLF2/4, EBNA2, VP16, HSF1, HSF2, HsfA, Gli3, Sox18, PIF, Dreb2a, MTF1, OREB1, WRKY45, NS1, MKL1, VP16, EBNA2, KBP220, ECapLL, P201, AH, and B42 transcription factors. We and others have shown that the activation domains 9aaTAD have competence to activate transcription as small peptides (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . We have established previously the 9aaTAD prediction service online (www.piskacek.org). The curated 9aaTAD activation domains had been annotated on protein database UniProt (www.uniprot.org/9aaTAD).
The Gal4 transcription factor was model eukaryotic activator used in the early 90s to study gene activation. In the Mark Ptashne lab, great efforts had been made to determine Gal4 activation domains. Multiple activation domains were reported in series of studies.
Nevertheless, we had found that all previously reported activation domains in the Gal4 have none considerable transactivation potential and are not involved in activation of transcription.
We demonstrated that artificial peptides included in the original Gal4 constructs (17) and fusion regions (18) were responsible for the artificial transcriptional activities in numerous reported Gal4 constructs (19) . All these artefacts produced enormous bias and misconception.
From the Gal4 ortholog study on the transcription factor Oaf1, we have reported new concept for activation domain. The activation domain 9aaTAD, we had identified in Oaf1, enabled us to identified further activation domain in the Gal4 family. We recognized the activation domain 9aaTAD in the Gal4 activator (857-871 aa) and experimentally proved it's ability to activate transcription (2) . The Gal4 activation domain 9aaTAD location did not correspond to any of the previously defined activation domains AD-I, AD-II or AD-III from Ptashne lab, but rather correlate with the Gal80 binding region and with the region deleted in Gal4 loss-offunction mutant (1-852 aa) (2) .
Strikingly, strong arguments for the 9aaTAD misconception were reported from Hahn lab, Warfield et al., 2014 , PNAS, edited by M.Ptashne (20) . According to the authors, the Gal4 9aaTAD domain is none functional activation domain and the 9aaTAD algorithm did not predict activation function. The 9aaTAD misconception was further worsen and disseminated by review Erkina and Erkine et al., 2016, Epigenetics & Chromatin (21) .
In this study, we revised the 9aaTAD misconception for the Gal4 activator (20, 21) . We identified a 9aaTAD adjacent inhibitory domain, which strongly reduced the 9aaTAD (20) , the construct with extraordinary strong and well defined Gal4 activation domain from the Ptashne lab (18) , was inactive in their system ( Fig. 1 ).
Materials and Methods

Constructs
The construct pBTM116-HA was generated by an insertion of the HA cassette into the EcoRI site of the vector pBTM116 (HA cassette nucleotide sequence: TGG CTG -GAATTA -GCC ACC ATG GCT TAC CCA TAC GAT GTT CCA GAT TAC GCT GTC GAG ATA -GAATTC, which render in amino acids sequence: 
Assessment of enzyme activities
The β -galactosidase activity was determined in the yeast strain L40 (4, 22 
Western Blot Analysis
The crude cell extracts were prepared in a buffer containing 200 mM Tris-HCl, pH 8.0, 1 mM EDTA, 
Results
Inhibition of the Gal4 9aaTAD by adjacent region
In the study Warfield et al., 2014, PNAS, edited by Mark Ptashne (20) , the ability of two Gal4 activation domains were assayed and evaluated head-to-head: i) the extraordinary strong activation domain defined by Ptashne lab (Gal4 840-860 aa) (18) , which served in their experiment as positive control and ii) the new-coming activation domain 9aaTAD, defined by our lab (Gal4 857-870 aa) (1, 2) . Their data showed that both constructs are almost inactive (Figure 1 ).
From our recent study (19) , we know well why their positive control, the activation domain defined by Ptashne lab, could not work in their experiments as a strong activator -reported errors in Ptashne constructs (3, 19) .
What we did not know, why their longer 9aaTAD construct with adjacent Gal4 region was inactive. Initially, we inspected the Gal4 constructs reported previously and identified a construct reported from Ptashne lab (17) , which included merely the activation domain 9aaTAD with the same adjacent Gal4 region (construct ID5-3S, Gal4 DNA binding domain 1-74 aa fused with C-terminal Gal4 region 851-881 aa; 0,05% activity of the construct pMA210 with full length sequence of the Gal4 protein, (17))( Fig. 2) . Also this construct was inactive, what indicate real experimental observation reported in Warfield et al. (20) .
Therefore, we supposed that the function of the 9aaTAD activation domain was inhibited by the Gal4 adjacent region in both constructs with the same inhibitory domain. The different hybrid systems used by Ptashne or Hahn lab could be therefore excluded for artificial inhibitory effects and rather natural Gal4 phenome could be expected (Gal4 DNA binding domain and Gcn4 DNA binding domain hybrids).
Noteworthy, the presence of inhibitory domains in Gal4 constructs are anymore surprising observations, because multiple inhibitory domains were already reported for the Gal4 protein (23) and could be expected in the inactive Gal4 constructs.
To test expected inhibition of the 9aaTAD activation domain by the adjacent region, we assayed the 9aaTAD activation domain in LexA hybrid assay with and without the adjacent region (LexA DNA binding domain hybrids with the GAL4 activation domain 9aaTAD). We have generated LexA construct G577 with the 9aaTAD activation domain (Gal4 857-871 aa, see protein expression in (19) ) and LexA construct G578 with adjacent Gal4 region according to the authors (Gal4 857-881 aa, see protein expression in (19) ). The activation functions of the LexA-Gal4 hybrids were monitored in L40 strain (2μ vector pBTM116 was used for all constructs; strain L40 with integrated lacZ reporter driven by lexA operator was used to assay the activation of transcription). The construct G578 with the activation domain 9aaTAD and adjacent Gal4 region was completely inactive, but the construct G577 (including merely the activation domain 9aaTAD) was strong activator, which activity exceed the activity of the Gal4 terminal constructs (19) . The sequence difference of analogous constructs determined presence of inhibitory domain in the Gal4 adjacent region ( Fig. 2) . Thus, our and authors results are in a good agreement (experimental conformity), just the presence of obligatory controls (positive control, which is not inactive in conducted experiment and which could activate transcription) and the conclusions made (logical conclusions) largely differ.
Re-activation of the inhibited activation domain 9aaTAD
The 9aaTAD re-activation could be observed in the Gal4 construct CD59X, which is 500 times more active as the shorter construct ID5-3S (CD59X: Gal4 DNA binding domain 1-74 aa, with adjacent Gal4 region 75-238 aa and C-terminal Gal4 region 851-881 aa; 29% activity of the construct pMA210 with full length sequence of the Gal4 protein; ID5-3S: Gal4
DNA binding domain 1-74 aa fused with C-terminal Gal4 region 851-881 aa; 0,05% activity of the construct pMA210 with full length sequence of the Gal4 protein, (17)).
From this could be concluded that the N-terminal region was responsible for re-activation, what we have further followed. This observation also reinforced presence of inhibitory domain in the original construct use by Warfield et al., 2014. Furthermore, the full length sequence of the Gal4 protein, which includes both activation domain 9aaTAD and adjacent inhibitory region is constitutively active (in the L40 strain, where inhibitory protein Gal80 is deleted) and strongly indicated the activation domain 9aaTAD re-activation. Therefore, there must be a region in the Gal4 protein, which interfere with the inhibitory domain and provided release of the activation domain 9aaTAD.
Because of the strong charging of both 9aaTAD activation domain and the C-terminal inhibitory domain, we have first tested N-terminal acidic region of the Gal4 protein for the 9aaTAD re-activation function. We have generated construct A578 by insertion of a cassette coding for FDWSEEDDMSDGLP peptide (Gal4 region 172-185 aa) in to the G578 construct, where the 9aaTAD domain function was inhibited by adjacent region. The construct A578 showed about 30% activity of the construct G577 including the activation domain 9aaTAD without adjacent region (positive control). The negative control (construct ADD) generated by insertion of the cassette coding for FDWSEEDDMSDGLP peptide in to construct missing the 9aaTAD domain, did not activate transcription at all ( Fig. 2) .
With further investigations, we could identified another Gal4 region with ability to interfere with the 9aaTAD adjacent inhibitory domain. The 9aaTAD re-activation could be observed in the construct ID-3, which is 300 times more active as the shorter construct ID5-3S (ID5-3: Fig. 1) .
The re-activation region II-short fully overlap with sequence of the reported construct Gal4 
Gal4 replicas are activation domains 9aaTAD
Previous study reported G80BP-A and G80BP-B peptides, which were selected from peptidelibrary by interaction with inhibitory protein Gal80 (24). Surprisingly, these Gal4 replicas were functional transactivation domains, which directly bind to mediator MED15 as original Gal4 TAD. The authors recognized well the structural and functional relationship between G80BP-A and G80BP-B peptides and the native domains. Nevertheless, the G80BP-A and G80BP-B peptides did not share significant similarity with the Gal4 activation domain (25).
We expect that both G80BP-A and G80BP-B peptides are solely Gal4 9aaTAD replicas selected in original screen by binding cavity of the inhibitory protein Gal80 (Fig. 3) . The fact, that there are any significant sequence similarity G80BP-A and G80BP-B peptides with Gal4 reflect promiscuous pattern of the 9aaTAD family. In both G80BP-A and G80BP-B peptides,
we have found putative activation domains 9aaTAD by our online 9aaTAD prediction. We generated LexA DNA binding domain constructs with the predicted nine amino acid long domains, which we considered as 9aaTAD replicas.
The resulted activities of the predicted activation domains 9aaTAD were comparable with the Gal4 activation domain 9aaTAD (Fig. 3) . Collectively, both Gal4 replicas are activation domains 9aaTAD, which are transcriptionally active. The G80BP-A and G80BP-B Gal4
replicas were assigned to the 9aaTAD family.
9aaTAD domain prediction and conservation in the Gal4 family
Recently reported, the 9aaTAD prediction algorithm is highly redundant nine-residue AD signatures and does not predict AD function in Gal4 transcription factor (20, 21) . Although, any prediction has limited accuracy and use, the 9aaTAD prediction made by our algorithm for the Gal4 activator well correlated with our experimental results. The online 9aaTAD prediction for the S.c.Gal4 protein revealed two hits, where one is in the DNA binding domain (false hit) and the second in the C-terminal region, which is well know activation domain ( Fig. 4) . The 9aaTAD prediction is useful for the Gal4 orthologs. The Gal4 orthologs were identified by ExPASy SIB BLAST. We found that the Gal4 activation domain 9aaTAD is conserved in the family (Fig. 5) . For the most distal Gal4 ortholog identified by us, so far, yeast Wickerhamomyces ciferrii, W.c.Gal4 (K0KTZ9_WICCF), we revealed a single prediction hit from the online 9aaTAD prediction. Noteworthy, the S.c.Gal4 and W.c.Gal4
have no homology in the C-terminal region (Fig. 5) with integrated lacZ reporter driven by lexA operator was used to assay the activation of transcription). The W.c.Gal4 9aaTAD strongly activated transcription and confirmed thus our correct 9aaTAD prediction ( Fig. 6 ).
Discussion
This report is in part a revision of the supposed 9aaTAD misconception (20, 21) and reported inhibitory and reactivation mechanism of activation domain 9aaTAD in Gal4 activator.
Technical errors, which generated the Gal4 dogmas and controversy, are clarified here.
The Gal4 Dogma #1 stood up for activation domains AD-I and AD-II and their acidic character (Ma and Ptashne et al. 1987, Cell) (17) . We had revised competence of the activation domains AD-I and AD-II to activate transcription. We found that both activation domains have none considerable transactivation potential and are not involved in activation of transcription (19) . The artificial peptides included in the original Gal4 constructs, an unintended consequence of cloning, were responsible for the artificial transcriptional activity.
The Gal4 Dogma #2 adhered on the strong activation domain AD-III (Gal4 840-857 aa, construct pRJR200)(3). Already the position of activation domain AD-III generated serious concern. Firstly, this activation domain was located outside of both previously reported activation domains AD-I and AD-II (18) . Furthermore, unlike the activation domain 9aaTAD, the AD-III position was outside of the region recognized by inhibitory protein Gal80 (27). We had revised reported experimental data and found that also this activation domain AD-III has none considerable transactivation potential and could not be involved in activation of transcription (19) . We had found that the part of the Gal4 DNA binding domain (region 92-100 aa) fused to part of the activation domain AD-III (region 840-843 aa) in the original construct from Ptashne lab generated strong artificial activation domain, another unintended consequence of cloning [19] . In agreement with authors, we also found that the 9aaTAD constructs with the adjacent region was inactivated. We identified inhibitory domain in the Gal4 C-terminal region, what explained our, their and others observations for various 9aaTAD constructs with and without adjacent region (17, 20) . The inhibition of the activation domain 9aaTAD had produced enormous bias and misconception in recent (20, 21) but also in the very earlier Gal4 studies (17) . Collectively, we could explained rationally all inconsistency in reported experiments by Warfield et al., 2014 (20) and rebut supposed 9aaTAD misconception.
The activation domain 9aaTAD is well conserved in the Gal4 family. The 9aaTAD algorithm recognized activation domains in S.c.Gal4 and other Gal4 orthologs and paralogs (2, 4) . To test predicted activation domain 9aaTAD for activation potential, LexA -Gal4 hybrids construct with predicted sequences were generated and tested. The LexA -Gal4 hybrid constructs (BTM116 backbone) were assayed in L40 strain for activation of transcription. The 
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